Skip to main
RARE
RARE logo

Ultragenyx Pharmaceutical (RARE) Earnings Dates & Reports

Ultragenyx Pharmaceutical (RARE) Most Recent Earnings

Report DateAug 5, 2025
Period EndingQ2 2025
Est. EPS-$1.30
Actual EPS-$1.17
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Ultragenyx Pharmaceutical (RARE) Earnings per Share (EPS) History

Signup for full access
Browse free

Ultragenyx Pharmaceutical (RARE) Latest Earnings

The value each RARE share was expected to gain vs. the value each share gained.

Ultragenyx Pharmaceutical (RARE) reported its most recent earnings on Aug 5, 2025 for Q2 2025, posting earnings per share (EPS) of -$1.17. This exceeded analysts' expectations of -$1.30 by 10.00%, marking a Beat.

For comparison, Ultragenyx Pharmaceutical reported EPS of -$1.52 in the same quarter last year.

The company is expected to announce its next earnings report on 11/04/2025, with analysts projecting an EPS of -$1.21.

Ultragenyx Pharmaceutical (RARE) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 4, 2025
-$1.21Next earnings call Nov. 4, 2025
Q2 2025Aug 5, 2025
-$1.30-$1.17-10.00%
Q1 2025May 6, 2025
-$1.64-$1.57-4.27%
Q4 2024Feb 13, 2025
-$1.27-$1.39+9.45%
Q3 2024Nov 5, 2024
-$1.45-$1.40-3.45%
View all

Ultragenyx Pharmaceutical (RARE) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Ultragenyx Pharmaceutical’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 5, 2025
May 6, 2025
Feb 13, 2025
Nov 5, 2024

Ultragenyx Pharmaceutical (RARE) Earnings FAQs

Ultragenyx Pharmaceutical (RARE) last reported earnings on Aug 5, 2025 for Q2 2025, posting an EPS of -$1.17, which Beat the estimate of -$1.30 by 10.00%.

For Q2 2025, Ultragenyx Pharmaceutical (RARE) reported an EPS of -$1.17, exceeding analysts' estimate of -$1.30 by 10.00%.

For Q2 2025, Ultragenyx Pharmaceutical (RARE) Beat expectations with an actual EPS of -$1.17 vs. an estimated EPS of -$1.30.

Following the last earnings report on Aug 5, 2025, Ultragenyx Pharmaceutical (RARE)'s stock price moved — from — to —.

The next Ultragenyx Pharmaceutical (RARE) earnings call is scheduled for Nov. 4, 2025, where executives will discuss financial results and outlook.

Ultragenyx Pharmaceutical (RARE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.